Understanding barriers to vaccination against invasive meningococcal disease: a survey of the knowledge gap and potential solutions

Figures & data

Figure 1. Awareness and knowledge of invasive meningococcal disease.

Question: “For each of the following pieces of information about meningitis (Germany only: meningitis [also known as meningococcal]), please tell us whether you already knew the information before reading it in this survey today”. Figure reports weighted data (all respondents, N = 3600). To see data stratified by country, see Supplementary Table S1.

Figure 2. Parental knowledge of (a) children’s vaccination status against invasive meningococcal disease serogroups and (b) meningitis B vaccination.

Question (a): “Which of the following statements best reflects whether your child(ren) has/have been vaccinated against meningitis (Germany only: meningitis [also known as meningococcal]). Please answer for each of your children”. Question (b): “Please select the statements that best describe your familiarity with each of the diseases listed below”. Figure reports weighted data ([a]: all children, n = 6702; [b]: all respondents, N = 3600). To see data stratified by country, see Supplementary Tables S2 and S3.

Figure 3. Discussion of meningitis B vaccine with a healthcare professional.

Question: “Have you ever discussed meningitis (Germany only: meningitis [also known as meningococcal]) B vaccination with your child’s doctor or another healthcare professional?”. Figure reports weighted data (all respondents, N = 3600). To see data stratified by country, see Supplementary Table S4.

Figure 4. Individual who initiated discussion regarding vaccination against invasive meningococcal disease.

Question: “Please think about the discussion you had with your child’s doctor (or another healthcare professional) about meningitis (Germany only: meningitis [also known as meningococcal]) B vaccination. Who initiated the conversation?”. Figure reports weighted data (all respondents, N = 3600). To see data stratified by country, see Supplementary Table S5.

Figure 5. Actions following completion of the survey.

Question: “How likely are you to do each of the following actions in relation to meningitis (Germany only: meningitis [also known as meningococcal]) vaccination in the next 3 months?”. Figure reports weighted data (all respondents, N = 3600). To see data stratified by country, see Supplementary Table S6.